Jaffetilchin Investment Partners LLC Has $440,000 Position in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Jaffetilchin Investment Partners LLC increased its stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 3.9% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 4,450 shares of the exchange traded fund’s stock after buying an additional 166 shares during the quarter. Jaffetilchin Investment Partners LLC’s holdings in SPDR S&P Biotech ETF were worth $440,000 at the end of the most recent reporting period.

Other large investors have also added to or reduced their stakes in the company. Concurrent Investment Advisors LLC boosted its holdings in shares of SPDR S&P Biotech ETF by 13.2% in the 1st quarter. Concurrent Investment Advisors LLC now owns 2,564 shares of the exchange traded fund’s stock valued at $243,000 after purchasing an additional 299 shares in the last quarter. Avantax Advisory Services Inc. lifted its stake in shares of SPDR S&P Biotech ETF by 17.2% in the 1st quarter. Avantax Advisory Services Inc. now owns 9,619 shares of the exchange traded fund’s stock valued at $913,000 after acquiring an additional 1,415 shares during the last quarter. Kingsview Wealth Management LLC lifted its stake in shares of SPDR S&P Biotech ETF by 3.8% in the 1st quarter. Kingsview Wealth Management LLC now owns 3,495 shares of the exchange traded fund’s stock valued at $332,000 after acquiring an additional 127 shares during the last quarter. HBK Sorce Advisory LLC lifted its stake in shares of SPDR S&P Biotech ETF by 2.6% in the 1st quarter. HBK Sorce Advisory LLC now owns 4,538 shares of the exchange traded fund’s stock valued at $431,000 after acquiring an additional 113 shares during the last quarter. Finally, Blair William & Co. IL raised its position in SPDR S&P Biotech ETF by 42.7% during the 1st quarter. Blair William & Co. IL now owns 150,562 shares of the exchange traded fund’s stock worth $14,287,000 after purchasing an additional 45,053 shares during the last quarter.

SPDR S&P Biotech ETF Stock Down 0.7 %

Shares of NYSEARCA:XBI opened at $103.50 on Tuesday. The firm has a market cap of $7.89 billion, a P/E ratio of 11.47 and a beta of 1.11. SPDR S&P Biotech ETF has a 12-month low of $64.99 and a 12-month high of $105.47. The business has a fifty day simple moving average of $99.00 and a 200 day simple moving average of $95.83.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.